Mark J Sculpher (Mark Sculpher)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Multidrug Resistant

Coronavirus Disease

Top Venues

Health technology assessment (Winchester, England)

Discover health systems

PharmacoEconomics

Health economics, policy, and law

This page only lists publications with an associated author ORCID identifier.

Publications

Megha Rao, Dominic Nkhoma, Sakshi Mohan, Pakwanja Twea, Benson Chilima, Joseph Mfutso-Bengo, Jessica Ochalek, Timothy B Hallett, Andrew N Phillips, Finn McGuire, Bethan Woods, Simon M Walker, Mark J Sculpher, Paul Revill
Using economic analysis to inform health resource allocation: lessons from Malawi. Discover health systems 3 (1) (2024)
Bethan Woods, Laetitia Schmitt, Dina Janković, Benjamin Kearns, Alison Scope, Shijie Ren, Tushar Srivastava, Chu-Chang Ku, Jean Hamilton, Claire Rothery, Laura Bojke, Mark J Sculpher, S E Harnan
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Health technology assessment (Winchester, England) 28 (28) (2024)
Bethan Woods, Laetitia Schmitt, Dina Janković, Benjamin Kearns, Alison Scope, Shijie Ren, Tushar Srivastava, Chu-Chang Ku, Jean Hamilton, Claire Rothery, Laura Bojke, Mark J Sculpher, S E Harnan
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Health technology assessment (Winchester, England) 28 (28) (2024)
Megha Rao, Dominic Nkhoma, Sakshi Mohan, Pakwanja Twea, Benson Chilima, Joseph Mfutso-Bengo, Jessica Ochalek, Timothy B Hallett, Andrew N Phillips, Finn McGuire, Bethan Woods, Simon M Walker, Mark J Sculpher, Paul Revill
Using economic analysis to inform health resource allocation: lessons from Malawi. Discover health systems 3 (1) (2024)
Bethan Woods, Laetitia Schmitt, Dina Janković, Benjamin Kearns, Alison Scope, Shijie Ren, Tushar Srivastava, Chu-Chang Ku, Jean Hamilton, Claire Rothery, Laura Bojke, Mark J Sculpher, S E Harnan
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Health technology assessment (Winchester, England) 28 (28) (2024)
Victoria Charlton, Michael J DiStefano, Polly Mitchell, Liz Morrell, Leah Zoe Gibson Rand, Gabriele Badano, Rachel Mairi Baker, Michael Calnan, Kalipso Chalkidou, Anthony J Culyer, Daniel Howdon, Dyfrig A Hughes, James Lomas, Catherine Max, Christopher McCabe, James F O'Mahony, Mike Paulden, Zack Pemberton-Whiteley, Annette Rid, Paul A Scuffham, Mark J Sculpher, Koonal Kirit Shah, Albert Weale, Gry Wester
We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment. Health economics, policy, and law (2023)
Thomas Patton, Paul Revill, Mark J Sculpher, Annick Borquez
Using Economic Evaluation to Inform Responses to the Opioid Epidemic in the United States: Challenges and Suggestions for Future Research. Substance use & misuse 57 (5) (2022)
Sakshi Mohan, Paul Revill, Stefano Malvolti, Melissa Malhame, Mark J Sculpher, Paul M Kaye
Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates. PLoS neglected tropical diseases 16 (6) (2022)
Mark J Sculpher, Stephen Palmer
After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator? PharmacoEconomics 38 (3) (2021)
Ana Duarte, Simon M Walker, Andrew Metry, Ruth Wong, Jasmina Panovska-Griffiths, Mark J Sculpher
Jointly Modelling Economics and Epidemiology to Support Public Policy Decisions for the COVID-19 Response: A Review of UK Studies. PharmacoEconomics 39 (8) (2021)
William V Padula, Mark J Sculpher
Ideas About Resourcing Health Care in the United States: Can Economic Evaluation Achieve Meaningful Use? Annals of internal medicine 174 (1) (2020)
Simon M Walker, Edward Cox, Ben Rothwell, Colin Berry, Gerry P McCann, Chiara Bucciarelli-Ducci, Erica Dall'Armellina, Abhiram Prasad, James Robert John Foley, Kenneth Mangion, Petra Bijsterveld, Colin C Everett, Deborah D Stocken, Sven Plein, John Pierre Greenwood, Mark J Sculpher
Cost-effectiveness of cardiovascular imaging for stable coronary heart disease. Heart (British Cardiac Society) 107 (5) (2020)
Joanna Emerson, Ari Panzer, Joshua T Cohen, Kalipso Chalkidou, Yot Teerawattananon, Mark J Sculpher, Thomas Wilkinson, Damian Walker, Peter J Neumann, David D Kim
Adherence to the iDSI reference case among published cost-per-DALY averted studies. PloS one 14 (5) (2019)